Safety, Tolerability, Pharmacokinetics and Efficacy of SCT-I10A in Patients With Advanced Solid Tumors or Lymphoma

NCT03821363 · clinicaltrials.gov ↗
PHASE1
Phase
UNKNOWN
Status
206
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Sinocelltech Ltd.